Latest Naloxone Stories
BUNAVAIL PDUFA date June 7, 2014; Pre-launch activities underway to support an anticipated late Q3 2014 launch RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International,
Passages Malibu CEO comments on enhanced access to treatment in the US. Malibu, CA (PRWEB) May 06, 2014
The auto-injector is designed to allow quick administration when drug overdose first occurs. LOS ANGELES, CA (PRWEB) April 09, 2014 Family members and
The auto-injector is designed to allow quick administration when drug overdose first occurs LOS ANGELES, April 8, 2014 /PRNewswire/ -- Family members and caregivers of individuals
First presentation of detailed BUNAVAIL clinical data scheduled for April 11 and 13, 2014 RALEIGH, N.C., April 7, 2014 /PRNewswire/ -- BioDelivery Sciences International,
RICHMOND, Va., April 7, 2014 /PRNewswire/ -- Kaleo (formerly Intelliject) today announced that it has entered into a $150 million debt facility with PDL BioPharma (NASDAQ: PDLI) to enable kaleo to
First and only naloxone product specifically intended for emergency administration by family members or caregivers in settings where opioids may be present RICHMOND, Va., April 3, 2014 /PRNewswire/
There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment.
Ashfield Market Access to provide managed markets and trade support RALEIGH, N.C., March 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
Developers Continue to Focus Efforts on Formulation Improvements, According to Findings from Decision Resources Group BURLINGTON, Mass., March 17, 2014 /PRNewswire/ -- Decision Resources Group
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.